Prevalence and spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae in Europe.

By R. Cantón, Â. Novais, A. Valverde, E. Machado, L. Peixe, F. Baquero, Teresa M. Coque. Clinical Microbiology and Infection, 2008

714 citations recorded by the source corpus.

Subfields: Molecular Biology, Molecular Medicine, Pollution

View Paper: https://www.semanticscholar.org/paper/c0152d599683917af26207a4f4403ddbccfd5394

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

1. P. Nordmann
2. T. Naas
3. A. Carattoli
4. L. Poirel

In Molecular Medicine

1. P. Nordmann
2. A. Carattoli
3. J. González-Alba
4. J. Galán
5. R. Cantón
6. T. Naas
7. Peter Hawkey
8. S. Navon-Venezia

In Pollution

1. C. Giske
2. R. Cantón
3. A. Carattoli
4. P. Nordmann

Citations in the corpus

• Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment. (2015, background): “Isolates with the CTX-M-9 group are common in Spain and strains with the CTX-M-3 enzymes have been described chiefly in Eastern Europe, although clones producing the CTX-M group 1 (including the CTX-M-15 type) are the most widespread throughout Europe (Coque et al., 2008a,b; Canton et al., 2008).”
• Klebsiella pneumoniae: a major worldwide source and shuttle for antibiotic resistance (2017, background): “In Israel and Spain, a prevalence of 40% of ESBL production among the total K. pneumoniae hospital isolates was reported (Navon-Venezia et al. 2003; Cantón et al. 2008).”
• CTX-M Enzymes: Origin and Diffusion (2012, background): “…general overview, within the CTX-M enzymes, the CTX-M-15, and CTX-M-14 are by far the most important ones, virtually invading all human and animal compartments as well as the environment all over the world (Cantón et al., 2008; Hawkey and Jones, 2009; Dolejska et al., 2011; Hiroi et al., 2012).”
• Extended-Spectrum β-Lactamase Genes of Escherichia coli in Chicken Meat and Humans, the Netherlands (2011, background): “This increase has been caused mainly by an increased prevalence of extended-spectrum β-lactamase (ESBL)–producing Enterobacteriaceae (3,4) and has increased the use of last-resort antimicrobial drugs (i.e., carbapenems).”
• Acquired Antibiotic Resistance Genes: An Overview (2011, background): “Over the last decades they have remained a reason for concern, but additional public health threats in relation to resistant microorganisms have also arisen (see for example Cantón et al., 2008; Goossens, 2009; Allen et al., 2010).”
• Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. (2012, background): “With ESBLs, it seems that, after quiet and continuous spread, outbursts occurred in many parts of the world, including Europe [14].”
• Extended-spectrum β-lactamase-producing and AmpC-producing Escherichia coli from livestock and companion animals, and their putative impact on public health: a global perspective. (2012, positive): “Almost one decade later, ESBL and AmpC b-lactamases have emerged worldwide, and CTX-M enzymes have now become the most widespread type of ESBL [9,10].”